Hemp Naturals Inc

PINK:HPMM USA Drug Manufacturers - Specialty & Generic
Market Cap
$132.13K
Market Cap Rank
#49783 Global
#15202 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$12.60
About

Hemp Naturals, Inc., an early stage company, focuses on researching, developing, acquiring, and selling products made of industrial hemp. The company offers rolling papers through 25 retail outlets, which include gas stations, convenience stores, tobacco shops, and liquor stores. It also intends to offer consumer goods that are made of industrial hemp and/or the non-psychoactive ingredients of th… Read more

Hemp Naturals Inc (HPMM) - Net Assets

Latest net assets as of February 2022: $1.52 Million USD

Based on the latest financial reports, Hemp Naturals Inc (HPMM) has net assets worth $1.52 Million USD as of February 2022.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.56 Million) and total liabilities ($37.80K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $1.52 Million
% of Total Assets 97.58%
Annual Growth Rate N/A
5-Year Change -57.39%
10-Year Change N/A
Growth Volatility 3168.89

Hemp Naturals Inc - Net Assets Trend (2015–2021)

This chart illustrates how Hemp Naturals Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Hemp Naturals Inc (2015–2021)

The table below shows the annual net assets of Hemp Naturals Inc from 2015 to 2021.

Year Net Assets Change
2021-11-30 $1.58 Million +490.87%
2020-11-30 $267.69K -64.19%
2019-11-30 $747.64K -88.19%
2018-11-30 $6.33 Million +70.55%
2017-11-30 $3.71 Million +8007.43%
2016-11-30 $45.78K +1626.54%
2015-11-30 $-3.00K --

Equity Component Analysis

This analysis shows how different components contribute to Hemp Naturals Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 3180477000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (November 2021)

Component Amount Percentage
Common Stock $174.63K 11.04%
Other Comprehensive Income $-174.63K -11.04%
Other Components $33.40 Million 2111.67%
Total Equity $1.58 Million 100.00%

Hemp Naturals Inc Competitors by Market Cap

The table below lists competitors of Hemp Naturals Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Hemp Naturals Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2020 to 2021, total equity changed from 267,691 to 1,581,723, a change of 1,314,032 (490.9%).
  • Net loss of 13,409,607 reduced equity.
  • Other comprehensive income decreased equity by 119,455.
  • Other factors increased equity by 14,843,094.

Equity Change Factors (2020 to 2021)

Factor Impact Contribution
Net Income $-13.41 Million -847.78%
Other Comprehensive Income $-119.45K -7.55%
Other Changes $14.84 Million +938.41%
Total Change $- 490.88%

Book Value vs Market Value Analysis

This analysis compares Hemp Naturals Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.10x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2015-11-30 $-0.15 $0.00 x
2016-11-30 $1.96 $0.00 x
2017-11-30 $49.28 $0.00 x
2018-11-30 $11.97 $0.00 x
2019-11-30 $1.36 $0.00 x
2020-11-30 $0.00 $0.00 x
2021-11-30 $0.00 $0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Hemp Naturals Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -847.78%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -107276.86%
  • • Asset Turnover: 0.01x
  • • Equity Multiplier: 1.02x
  • Recent ROE (-847.78%) is below the historical average (-369.82%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2015 0.00% 0.00% 0.00x 0.00x $-171.53K
2016 -79.46% 0.00% 0.00x 1.06x $-40.96K
2017 -107.05% 0.00% 0.00x 1.00x $-4.34 Million
2018 -102.64% 0.00% 0.00x 1.16x $-7.13 Million
2019 -833.77% -904723.37% 0.00x 2.40x $-6.31 Million
2020 -618.07% 0.00% 0.00x 4.75x $-1.68 Million
2021 -847.78% -107276.86% 0.01x 1.02x $-13.57 Million

Industry Comparison

This section compares Hemp Naturals Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Hemp Naturals Inc (HPMM) $1.52 Million 0.00% 0.02x $170.54
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million